FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Inari Medical, Inc. - NARI
Inari Medical, Inc. (NARI)
Company Research
Source: GlobeNewswire
CEDARHURST, N.Y., May 15, 2024 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Inari Medical, Inc. (NasdaqGS: NARI), if they purchased the Company’s shares between February 24, 2022 and February 28, 2024. Shareholders have until July 12, 2024 to file lead plaintiff applications in the securities class action lawsuit. Shareholders are encouraged to contact us at https://kclasslaw.com/cases/securities/nasdaqgs-nari/, by calling toll-free at 1-833-835-1495 or by email (dk@kclasslaw.com). Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:Kuznic
Show less
Read more
Impact Snapshot
Event Time:
NARI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NARI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NARI alerts
High impacting Inari Medical, Inc. news events
Weekly update
A roundup of the hottest topics
NARI
News
- Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Truist Financial Co. from $46.00 to $50.00. They now have a "hold" rating on the stock.MarketBeat
- PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary EmbolismGlobeNewswire
- Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Canaccord Genuity Group Inc. from $71.00 to $74.00. They now have a "buy" rating on the stock.MarketBeat
- Inari Medical, Inc. (NASDAQ: NARI) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Piper Sandler from $50.00 to $52.00. They now have a "neutral" rating on the stock.MarketBeat
NARI
Earnings
- 10/28/24 - Miss
NARI
Sec Filings
- 10/31/24 - Form 4
- 10/31/24 - Form 4
- 10/29/24 - Form 144
- NARI's page on the SEC website